Post-transplant lymphoproliferative disorder risk and outcomes in renal transplant patients treated with belatacept immunosuppression

@bonnaud_dowell @dommibertrand @JASN_News @kbudde @ChariteBerlin @NDTsocial @CHURouen @ChuBrest No we didn't observed an increase risk (to note all patients were EBV seropositive at time of conversion). In addition, @EmoryUniversity recently published a pa